Immunoassay Market Analysis and Forecast to 2031: By Technology (ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT, PCR), Product & Service (Reagents & Kits, Analyzers, Software Services), Application (Infectious Dise
Description
Immunoassay Market Analysis and Forecast to 2031: By Technology (ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT, PCR), Product & Service (Reagents & Kits, Analyzers, Software Services), Application (Infectious Diseases, Endocrinology, Cardiology, Oncology, Hematology), End User (Hospitals, Clinical Laboratories, Blood Banks, Academic Research Centers, Pharmaceutical Companies, Biotechnology Companies, Others), and Region
The global immunoassay market was valued at USD 28.0 billion in 2021 and it is anticipated to grow further up to USD 46.3 billion by 2031, at a CAGR of 5.2% during the forecast period.
A test known as an immunoassay uses an antibody or immunoglobulin to measure the concentration of a macromolecule in a solution. The analyte is the term for the discovered large molecule. For medical and scientific purposes, immunoassay is used to measure the number of analytes in serum and urine. To guarantee the correctness of the results acquired, it is also utilized in qualitative, quantitative, and radioactivity procedures. Immunoassays with high specificity and sensitivity are utilized to speed up the reactions.
Market Trends and Drivers
The rise in chronic and infectious disorders, especially the COVID-19 outbreak, is responsible for the market expansion. Growth will also be aided by the increase in the elderly population, who are more susceptible to infections and chronic diseases. The widespread use of immunoassay techniques in illness diagnostics is a result of a rise in the incidence of chronic ailments such cancer, infections, cardiovascular diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases. The prevalence of cancer is gradually rising, which is anticipated to increase need for efficient diagnostic tools like immunoassay. This method is important for determining oncogenesis and diagnosing cancer in all of its forms, including benign and malignant cancer.
Market Restraints and Challenges
The commercialization of the Immunoassay device and consumables is now subject to regulation by the government and regulatory agencies in various countries. It has grown to be a significant obstacle for the immunoassay market. In addition, the industry for immunoassay will be hampered by technological challenges brought on by immunoassay reagents and kits, such as low detection limits of the available antibodies, cross-reactivity of the antibodies, and misleading results.
Global Immunoassay Market Segmental Overview
The report analyses the global immunoassay market based on technology, product & services, application, end user, and region.
Global Immunoassay Market by Technology
Based on the technology, it is segmented into ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT, and PCR. The ELISA segment is likely to dominate the market during the forecast period. The key factors such as the requirement of relatively lesser antisera to carry out the analysis reduced assay time and quantitative results.
Global Immunoassay Market by Product & Services
Based on the products & services, it is segmented into reagents & kits, analyzers, and software services. The reagents & kits segment is anticipated to dominate the market during the forecast period. The key factor such as high demand for effective diagnostic purposes is boosting the growth of the market.
Global Immunoassay Market by Application
Based on the application, it is segmented into infectious diseases, endocrinology, cardiology, oncology, and hematology. The infectious testing segment is anticipated to dominate the market during the forecast period. The large share of the market can be attributed to a rising number of cases of Malaria, Dengue, HIV, and novel Coronavirus cases across the globe.
Global Immunoassay Market by End User
Based on the end user, it is segmented into hospitals, clinical laboratories, blood banks, academic research centers, pharmaceutical companies, biotechnology companies, and others. The hospital segment is anticipated to dominate the market during the forecast period. The high share can be owing to a rising number of hospitals and clinics, developing healthcare infrastructure, a rise in the number of chronic diseases, and the ongoing incremental demand for testing kits for the detection of COVID-19.
Geographical Analysis of the Global Immunoassay Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North America region is anticipated to dominate the market during the forecast period. Due to the region's high prevalence of chronic diseases, particularly a rise in the incidence of cancer, its established healthcare infrastructure, adoption of cutting-edge technologies, and the presence of major international firms, North America currently has a dominant position in the market.
Major Players in the Global Immunoassay Market
COVID-19 Impact
The immunoassay product is essential for preventing the coronavirus from spreading. The only effective strategy to control the spread of diseases and the potential number of casualties in the absence of a vaccination or treatment is to diagnose them. For extensive COVID-19 monitoring, rapid testing has demonstrated to be an efficient, quick, and simple molecular assay. The challenges associated with SARS-CoV2 detection have been reduced as a result of in-depth investigation, evaluation, and authorization of several immunoassay products and analyzers. There has been a rise in the use of immunoassays such as chemiluminescence, enzyme-linked, lateral flow-based point of therapy diagnostics, rapid testing, and other methods. Demanding regulatory requirements for immunoassay product approval and the technological difficulties with immunoassay products and reagents have an impact on the market. Throughout the epidemic, the immunoassay business has experienced great growth in numerous countries as a result of the widespread diagnosis of COVID-19. Additionally, the market is anticipated to grow even more with the third wave's increase in COVID-19 cases.
Recent Developments
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
The global immunoassay market was valued at USD 28.0 billion in 2021 and it is anticipated to grow further up to USD 46.3 billion by 2031, at a CAGR of 5.2% during the forecast period.
A test known as an immunoassay uses an antibody or immunoglobulin to measure the concentration of a macromolecule in a solution. The analyte is the term for the discovered large molecule. For medical and scientific purposes, immunoassay is used to measure the number of analytes in serum and urine. To guarantee the correctness of the results acquired, it is also utilized in qualitative, quantitative, and radioactivity procedures. Immunoassays with high specificity and sensitivity are utilized to speed up the reactions.
Market Trends and Drivers
The rise in chronic and infectious disorders, especially the COVID-19 outbreak, is responsible for the market expansion. Growth will also be aided by the increase in the elderly population, who are more susceptible to infections and chronic diseases. The widespread use of immunoassay techniques in illness diagnostics is a result of a rise in the incidence of chronic ailments such cancer, infections, cardiovascular diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases. The prevalence of cancer is gradually rising, which is anticipated to increase need for efficient diagnostic tools like immunoassay. This method is important for determining oncogenesis and diagnosing cancer in all of its forms, including benign and malignant cancer.
Market Restraints and Challenges
The commercialization of the Immunoassay device and consumables is now subject to regulation by the government and regulatory agencies in various countries. It has grown to be a significant obstacle for the immunoassay market. In addition, the industry for immunoassay will be hampered by technological challenges brought on by immunoassay reagents and kits, such as low detection limits of the available antibodies, cross-reactivity of the antibodies, and misleading results.
Global Immunoassay Market Segmental Overview
The report analyses the global immunoassay market based on technology, product & services, application, end user, and region.
Global Immunoassay Market by Technology
Based on the technology, it is segmented into ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT, and PCR. The ELISA segment is likely to dominate the market during the forecast period. The key factors such as the requirement of relatively lesser antisera to carry out the analysis reduced assay time and quantitative results.
Global Immunoassay Market by Product & Services
Based on the products & services, it is segmented into reagents & kits, analyzers, and software services. The reagents & kits segment is anticipated to dominate the market during the forecast period. The key factor such as high demand for effective diagnostic purposes is boosting the growth of the market.
Global Immunoassay Market by Application
Based on the application, it is segmented into infectious diseases, endocrinology, cardiology, oncology, and hematology. The infectious testing segment is anticipated to dominate the market during the forecast period. The large share of the market can be attributed to a rising number of cases of Malaria, Dengue, HIV, and novel Coronavirus cases across the globe.
Global Immunoassay Market by End User
Based on the end user, it is segmented into hospitals, clinical laboratories, blood banks, academic research centers, pharmaceutical companies, biotechnology companies, and others. The hospital segment is anticipated to dominate the market during the forecast period. The high share can be owing to a rising number of hospitals and clinics, developing healthcare infrastructure, a rise in the number of chronic diseases, and the ongoing incremental demand for testing kits for the detection of COVID-19.
Geographical Analysis of the Global Immunoassay Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North America region is anticipated to dominate the market during the forecast period. Due to the region's high prevalence of chronic diseases, particularly a rise in the incidence of cancer, its established healthcare infrastructure, adoption of cutting-edge technologies, and the presence of major international firms, North America currently has a dominant position in the market.
Major Players in the Global Immunoassay Market
COVID-19 Impact
The immunoassay product is essential for preventing the coronavirus from spreading. The only effective strategy to control the spread of diseases and the potential number of casualties in the absence of a vaccination or treatment is to diagnose them. For extensive COVID-19 monitoring, rapid testing has demonstrated to be an efficient, quick, and simple molecular assay. The challenges associated with SARS-CoV2 detection have been reduced as a result of in-depth investigation, evaluation, and authorization of several immunoassay products and analyzers. There has been a rise in the use of immunoassays such as chemiluminescence, enzyme-linked, lateral flow-based point of therapy diagnostics, rapid testing, and other methods. Demanding regulatory requirements for immunoassay product approval and the technological difficulties with immunoassay products and reagents have an impact on the market. Throughout the epidemic, the immunoassay business has experienced great growth in numerous countries as a result of the widespread diagnosis of COVID-19. Additionally, the market is anticipated to grow even more with the third wave's increase in COVID-19 cases.
Recent Developments
- February 2021, Thermo Fisher Scientific Inc., acquired Mesa Biotech which is the private point of care molecular diagnostic company.
- January 2021, Abbott received the CE Mark for its Panbio COVID-19 Ag Rapid Test Device for the asymptomatic diagnosis of the SARS-CoV-2 virus. It also offers self-swabbing.
- December 2020, Beckmann Coulter, the part of Danaher company, launched the first high-quality and throughput assay called Access SARS-CoV-2 Antigen assay, for the COVID-19 antigen assay, for the COVID-19 antigen diagnosis, in the US.
- October 2020, Thermo Fisher Scientific launched its ELIA SARS-CoV-2-Sp1 IgG test and OmniPATH COVID-19 Total Antibody ELISA test to diagnose COVID-19 antibodies.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
179 Pages
- Chapter 1. Market Introduction
- 1.1. Objectives Of the Study
- 1.2. Market Definition and Research & Scope
- 1.3. Research Methodologies
- 1.4. Market Estimation Techniques
- Chapter 2. Executive Summary
- 2.1. Summary
- 2.2. Key Highlights of The Market
- Chapter 3. Immunoassay Market Outlook
- 3.1. Immunoassay Market Segmentation
- 3.2. Market Dynamics
- 3.2.1. Market Drivers
- 3.2.1.1. Driver 1
- 3.2.1.2. Driver 2
- 3.2.1.3. Driver 3
- 3.2.2. Market Restraints
- 3.2.2.1. Restraint 1
- 3.2.2.2. Restraint 2
- 3.2.3. Market Opportunities
- 3.2.3.1. Opportunity 1
- 3.2.3.2. Opportunity 2
- 3.3. Porter’s Five Forces Analysis
- 3.3.1. Threat Of New Entrants
- 3.3.2. Threat Of Substitutes
- 3.3.3. Bargaining Power of Buyers
- 3.3.4. Bargaining Power of Supplier
- 3.3.5. Competitive Rivalry
- 3.4. Pestle Analysis
- 3.5. Value Chain Analysis
- 3.5.1. Raw Material Suppliers
- 3.5.2. Manufacturers
- 3.5.3. Wholesalers And/or Retailers
- 3.6. Impact Of the Russia and Ukraine War on The Global Immunoassay Market
- Chapter 4. The Economic Impact of Covid-19
- 4.1. Overall Impact of Covid-19
- 4.2. Impact Of Covid on The Global Immunoassay Market
- 4.3. Economic Impact Analysis
- Chapter 5. Immunoassay Market by Technology
- 5.1. Market Overview
- 5.2. ELISA
- 5.2.1. Market Size and Forecast, 2021-2031 ($Million)
- 5.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 5.3. Fluorescence
- 5.3.1. Market Size and Forecast, 2021-2031 ($Million)
- 5.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 5.4. Colorimetric
- 5.4.1. Market Size and Forecast, 2021-2031 ($Million)
- 5.4.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 5.5. Chemiluminescence
- 5.5.1. Market Size and Forecast, 2021-2031 ($Million)
- 5.5.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 5.6. Rapid Test
- 5.6.1. Market Size and Forecast, 2021-2031 ($Million)
- 5.6.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 5.7. Western Blot
- 5.7.1. Market Size and Forecast, 2021-2031 ($Million)
- 5.7.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 5.8. ELISPOT
- 5.8.1. Market Size and Forecast, 2021-2031 ($Million)
- 5.8.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 5.9. PCR
- 5.9.1. Market Size and Forecast, 2021-2031 ($Million)
- 5.9.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- Chapter 6. Immunoassay Market by Product & Services
- 6.1. Market Overview
- 6.2. Reagents & Kits
- 6.2.1. Market Size and Forecast, 2021-2031 ($Million)
- 6.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 6.3. Analyzers
- 6.3.1. Market Size and Forecast, 2021-2031 ($Million)
- 6.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 6.4. Software Services
- 6.4.1. Market Size and Forecast, 2021-2031 ($Million)
- 6.4.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- Chapter 7. Immunoassay Market by Application
- 7.1. Market Overview
- 7.2. Infectious Diseases
- 7.2.1. Market Size and Forecast, 2021-2031 ($Million)
- 7.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 7.3. Endocrinology
- 7.3.1. Market Size and Forecast, 2021-2031 ($Million)
- 7.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 7.4. Cardiology
- 7.4.1. Market Size and Forecast, 2021-2031 ($Million)
- 7.4.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 7.5. Oncology
- 7.5.1. Market Size and Forecast, 2021-2031 ($Million)
- 7.5.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 7.6. Hematology
- 7.6.1. Market Size and Forecast, 2021-2031 ($Million)
- 7.6.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- Chapter 8. Immunoassay Market by End User
- 8.1. Market Overview
- 8.2. Hospitals
- 8.2.1. Market Size and Forecast, 2021-2031 ($Million)
- 8.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 8.3. Clinical Laboratories
- 8.3.1. Market Size and Forecast, 2021-2031 ($Million)
- 8.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 8.4. Blood Banks
- 8.4.1. Market Size and Forecast, 2021-2031 ($Million)
- 8.4.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 8.5. Academic Research Centers
- 8.5.1. Market Size and Forecast, 2021-2031 ($Million)
- 8.5.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 8.6. Pharmaceutical Companies
- 8.6.1. Market Size and Forecast, 2021-2031 ($Million)
- 8.6.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 8.7. Biotechnology Companies
- 8.7.1. Market Size and Forecast, 2021-2031 ($Million)
- 8.7.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 8.8. Others
- 8.8.1. Market Size and Forecast, 2021-2031 ($Million)
- 8.8.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- Chapter 9. Global Immunoassay Market, By Region
- 9.1. Overview
- 9.2. North America
- 9.2.1. Key Market Trends and Opportunities
- 9.2.2. North America Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.2.3. North America Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.2.4. North America Immunoassay Market Size and Forecast by Country, 2021-2031, ($Million)
- 9.2.5. The U.S.
- 9.2.5.1. The U.S. Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.2.5.2. The U.S. Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.2.6. Canada
- 9.2.6.1. Canada Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.2.6.2. Canada Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.2.7. Mexico
- 9.2.7.1. Mexico Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.2.7.2. Mexico Immunoassay Market Size and Forecast by End User Technology, 2021-2031, ($Million)
- 9.3. Europe
- 9.3.1. Key Market Trends and Opportunities
- 9.3.2. Europe Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.3.3. Europe Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.4. Europe Immunoassay Market Size and Forecast by Country, 2021-2031, ($Million)
- 9.3.5. Germany
- 9.3.5.1. Germany Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.3.5.2. Germany Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.6. France
- 9.3.6.1. France Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.3.6.2. France Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.7. U.K.
- 9.3.7.1. U.K. Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.3.7.2. U.K. Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.8. Spain
- 9.3.8.1. Spain Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.3.8.2. Spain Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.9. Italy
- 9.3.9.1. Italy Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.3.9.2. Italy Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.10. Russia
- 9.3.10.1. Russia Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.3.10.2. Russia Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.11. Rest Of Europe
- 9.3.11.1. Rest Of Europe Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.3.11.2. Rest Of Europe Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4. Asia-Pacific
- 9.4.1. Key Market Trends and Opportunities
- 9.4.2. Asia-Pacific Immunoassay Market Size and Forecast by Country, 2021-2031, ($Million)
- 9.4.3. Asia-Pacific Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.4.4. Asia-Pacific Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4.5. China
- 9.4.5.1. China Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.4.5.2. China Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4.6. India
- 9.4.6.1. India Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.4.6.2. India Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4.7. Japan
- 9.4.7.1. Japan Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.4.7.2. Japan Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4.8. South Korea
- 9.4.8.1. South Korea Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.4.8.2. South Korea Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4.9. Rest Of APAC
- 9.4.9.1. Rest Of APAC Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.4.9.2. Rest Of APAC Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.5. Rest Of the World
- 9.5.1. Key Market Trends and Opportunities
- 9.5.2. Rest Of the World Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.5.3. Rest Of the World Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.5.4. Rest Of the World Immunoassay Market Size and Forecast by Country, 2021-2031, ($Million)
- 9.5.5. Latin America
- 9.5.5.1. Latin America Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.5.5.2. Latin America Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.5.6. Middle East
- 9.5.6.1. Middle East Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.5.6.2. Middle East Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.5.7. Africa
- 9.5.7.1. Africa Immunoassay Market Size and Forecast by Technology, 2021-2031, ($Million)
- 9.5.7.2. Africa Immunoassay Market Size and Forecast by End User, 2021-2031, ($Million)
- Chapter 10. Competitive Landscape
- 10.1. Market Overview
- 10.2. Market Share Analysis/Key Player Positioning
- 10.3. Developmental Strategy Benchmarking
- 10.3.1. New End User Development
- 10.3.2. Technology Launches
- 10.3.3. Business Expansions
- 10.3.4. Partnerships, Joint Ventures, And Collaborations
- 10.3.5. Mergers And Acquisitions
- Chapter 11. Company Profiles
- 11.1. Roche Diagnostics Limited
- 11.1.1. Company Snapshot
- 11.1.2. Financial Performance
- 11.1.3. Technology Offerings
- 11.1.4. Key Strategic Initiatives
- 11.1.5. SWOT Analysis
- 11.2. Siemens Healthcare
- 11.2.1. Company Snapshot
- 11.2.2. Financial Performance
- 11.2.3. Technology Offerings
- 11.2.4. Key Strategic Initiatives
- 11.2.5. SWOT Analysis
- 11.3. Abbott Laboratories
- 11.3.1. Company Snapshot
- 11.3.2. Financial Performance
- 11.3.3. Technology Offerings
- 11.3.4. Key Strategic Initiatives
- 11.3.5. SWOT Analysis
- 11.4. Beckman Coulter
- 11.4.1. Company Snapshot
- 11.4.2. Financial Performance
- 11.4.3. Technology Offerings
- 11.4.4. Key Strategic Initiatives
- 11.4.5. SWOT Analysis
- 11.5. Ortho Clinical Diagnostics
- 11.5.1. Company Snapshot
- 11.5.2. Financial Performance
- 11.5.3. Technology Offerings
- 11.5.4. Key Strategic Initiatives
- 11.5.5. SWOT Analysis
- 11.6. BioMrieux
- 11.6.1. Company Snapshot
- 11.6.2. Financial Performance
- 11.6.3. Technology Offerings
- 11.6.4. Key Strategic Initiatives
- 11.6.5. SWOT Analysis
- 11.7. Bio-Rad Laboratories Inc.
- 11.7.1. Company Snapshot
- 11.7.2. Financial Performance
- 11.7.3. Technology Offerings
- 11.7.4. Key Strategic Initiatives
- 11.7.5. SWOT Analysis
- 11.8. Sysmex Corporation
- 11.8.1. Company Snapshot
- 11.8.2. Financial Performance
- 11.8.3. Technology Offerings
- 11.8.4. Key Strategic Initiatives
- 11.8.5. SWOT Analysis
- 11.9. Becton, Dickinson & Company
- 11.9.1. Company Snapshot
- 11.9.2. Financial Performance
- 11.9.3. Technology Offerings
- 11.9.4. Key Strategic Initiatives
- 11.9.5. SWOT Analysis
- *The List of Company Is Subject to Change During the Final Compilation of The Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
